Terms: = Sarcomas AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12 AND Diagnosis
31 results:
1. CD30 expression in an emerging group of mesenchymal spindle cell neoplasms with ALK fusion detected by flow cytometry and immunohistochemistry.
Iwakoshi A; Kikui H; Nakashima R; Goto Y; Ichikawa D; Sasaki E; Sekimizu M; Hattori H; Maeda N
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23228. PubMed ID: 38380728
[TBL] [Abstract] [Full Text] [Related]
2. Novel KMT2B gene mutation in MUC4 positive low-grade fibromyxoid sarcoma.
Zhang L; Luo L; Liu C; Li Z
Diagn Pathol; 2024 Feb; 19(1):30. PubMed ID: 38347522
[TBL] [Abstract] [Full Text] [Related]
3. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
4. [diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
[TBL] [Abstract] [Full Text] [Related]
5. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
Fanburg-Smith JC; Smith JD; Flemming DJ
Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
[TBL] [Abstract] [Full Text] [Related]
6. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
[TBL] [Abstract] [Full Text] [Related]
7. Portuguese Consensus Recommendations for Next-Generation Sequencing of Lung Cancer, Rare Tumors, and Cancers of Unknown Primary Origin in Clinical Practice.
R Teixeira M; Oliveira J; Borralho P; O Fernandes MG; Almodovar T; Fernandes I; Macedo D; Ferreira A; Barroso A; Teixeira E; Machado JC
Acta Med Port; 2022 Sep; 35(9):677-690. PubMed ID: 35816050
[TBL] [Abstract] [Full Text] [Related]
8. Mesenchymal neoplasms with NTRK and other kinase gene alterations.
Davis JL; Al-Ibraheemi A; Rudzinski ER; Surrey LF
Histopathology; 2022 Jan; 80(1):4-18. PubMed ID: 34958503
[TBL] [Abstract] [Full Text] [Related]
9. Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings.
Khanna L; Prasad SR; Yedururi S; Parameswaran AM; Marcal LP; Sandrasegaran K; Tirumani SH; Menias CO; Katabathina VS
Radiographics; 2021; 41(3):876-894. PubMed ID: 33891523
[TBL] [Abstract] [Full Text] [Related]
10. Neurofibrosarcoma Revisited: An Institutional Case Series of Uterine sarcomas Harboring Kinase-related Fusions With Report of a Novel FGFR1-TACC1 Fusion.
Devereaux KA; Weiel JJ; Mills AM; Kunder CA; Longacre TA
Am J Surg Pathol; 2021 May; 45(5):638-652. PubMed ID: 33481389
[TBL] [Abstract] [Full Text] [Related]
11. [Gene Fusions as Acquired Resistance Mechanisms of EGFR-TKI].
Shao Y; Zhong D
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):381-387. PubMed ID: 32429639
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic utility of pan-Trk immunohistochemistry for inflammatory myofibroblastic tumours.
Yamamoto H; Nozaki Y; Kohashi K; Kinoshita I; Oda Y
Histopathology; 2020 Apr; 76(5):774-778. PubMed ID: 31578734
[TBL] [Abstract] [Full Text] [Related]
13. Next-Generation Sequencing in the diagnosis of Rare Pediatric Sinonasal Tumors.
Ahmed AA; Vundamati D; Farooqi M; Repnikova E; Zinkus T; Hetherington M; Paulson L
Ear Nose Throat J; 2021 Jun; 100(5):NP263-NP268. PubMed ID: 31550935
[TBL] [Abstract] [Full Text] [Related]
14. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
Stenman A; Zedenius J; Juhlin CC
Langenbecks Arch Surg; 2018 Sep; 403(6):785-790. PubMed ID: 29779047
[TBL] [Abstract] [Full Text] [Related]
15. Population-level effect of molecular testing and targeted therapy in patients with advanced pulmonary adenocarcinoma: a prospective cohort study.
Schwegler C; Kaufmann D; Pfeiffer D; Aebi S; Diebold J; Gautschi O
Virchows Arch; 2018 Apr; 472(4):581-588. PubMed ID: 29198034
[TBL] [Abstract] [Full Text] [Related]
16.
Yoshimoto T; Tanaka M; Homme M; Yamazaki Y; Takazawa Y; Antonescu CR; Nakamura T
Cancer Res; 2017 Jun; 77(11):2927-2937. PubMed ID: 28404587
[No Abstract] [Full Text] [Related]
17. Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.
Tanaka K; Hida T; Oya Y; Yoshida T; Shimizu J; Mizuno T; Kuroda H; Sakakura N; Yoshimura K; Horio Y; Sakao Y; Yatabe Y
Cancer; 2017 May; 123(10):1731-1740. PubMed ID: 28177518
[TBL] [Abstract] [Full Text] [Related]
18. Extraskeletal osteosarcoma of the orbit: A clinicopathologic case report and review of literature.
de Maeyer VM; Kestelyn PA; Shah AD; Van Den Broecke CM; Denys HG; Decock CE
Indian J Ophthalmol; 2016 Sep; 64(9):687-689. PubMed ID: 27853024
[TBL] [Abstract] [Full Text] [Related]
19. Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature.
Maher OM; Khatua S; Mukherjee D; Olar A; Lazar A; Luthra R; Liu D; Wu J; Ketonen L; Zaky W
J Neurooncol; 2016 Mar; 127(1):155-63. PubMed ID: 26718692
[TBL] [Abstract] [Full Text] [Related]
20. The PDCD4/miR-21 pathway in medullary thyroid carcinoma.
Pennelli G; Galuppini F; Barollo S; Cavedon E; Bertazza L; Fassan M; Guzzardo V; Pelizzo MR; Rugge M; Mian C
Hum Pathol; 2015 Jan; 46(1):50-7. PubMed ID: 25316501
[TBL] [Abstract] [Full Text] [Related]
[Next]